Cargando…
Glucocorticoid therapy in respiratory illness: bench to bedside
Each year, hundreds of millions of individuals are affected by respiratory disease leading to approximately 4 million deaths. Most respiratory pathologies involve substantially dysregulated immune processes that either fail to resolve the underlying process or actively exacerbate the disease. Theref...
Autores principales: | Amratia, Dhruv Atool, Viola, Hannah, Ioachimescu, Octavian C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726965/ https://www.ncbi.nlm.nih.gov/pubmed/35764344 http://dx.doi.org/10.1136/jim-2021-002161 |
Ejemplares similares
-
Glucocorticoid Signaling Pathway: From Bench to Bedside
por: Nicolaides, Nicolas C., et al.
Publicado: (2023) -
Bench-to-bedside review: Chloride in critical illness
por: Yunos, Nor'azim Mohd, et al.
Publicado: (2010) -
CDG Therapies: From Bench to Bedside
por: Brasil, Sandra, et al.
Publicado: (2018) -
Bench-to-bedside review: The role of glycosaminoglycans in respiratory disease
por: Souza-Fernandes, Alba B, et al.
Publicado: (2006) -
Bench-to-bedside review: Iron metabolism in critically ill patients
por: Darveau, Martin, et al.
Publicado: (2004)